Keyphrases
Treatment Options
100%
Adiponectin
100%
Insulin Sensitivity
100%
Failure Rate
100%
Cell Function
100%
Type 2 Diabetes Mellitus (T2DM)
100%
Racial Disparities
100%
Non-Hispanic White
100%
Treatment Failure
100%
Disparities in Treatment
100%
High-molecular-weight Adiponectin
71%
Metformin
42%
Racial-ethnic Groups
42%
Race-ethnicity
28%
Oral Disposition Index
28%
C-peptide Index
28%
Hazard Ratio
14%
Treatment Response
14%
B Cells
14%
Oral Glucose Tolerance Test
14%
Diminutive
14%
Temporal Change
14%
Hispanic
14%
Rosiglitazone
14%
Youth Studies
14%
Combined Hazards
14%
Therapeutic Failure
14%
Medicine and Dentistry
Adiponectin
100%
Maturity Onset Diabetes of the Young
100%
Insulin Sensitivity
100%
Cell Function
100%
Ethnic Disparity
100%
Diabetes in Adolescents
100%
Treatment Option
100%
Ethnic Group
42%
Glycon
28%
C-Peptide
28%
Glycemic
28%
Oral
28%
Biological Marker
14%
Treatment Response
14%
Hazard Ratio
14%
Research Design
14%
Oral Glucose Tolerance Test
14%
Metformin Plus Rosiglitazone
14%
Biochemistry, Genetics and Molecular Biology
Insulin Sensitivity
100%
Cell Function
100%
Adiponectin
100%
Molecular Weight
71%
C-Peptide
28%
Rosiglitazone
14%
Pharmacology, Toxicology and Pharmaceutical Science
Adiponectin
100%
Maturity Onset Diabetes of the Young
100%
C Peptide
28%
Metformin
28%
Biological Marker
14%
Metformin Plus Rosiglitazone
14%